New You, Inc.
$0.00$0.00 (0.0%)
New You, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
OTC · GENN · USD
Stock price, dividends, earnings
Quote as of Jul 23, 2025, 12:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Genesis Healthcare, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.97% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Genesis Healthcare, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Headquartered in Kennett Square, Pennsylvania, Genesis Healthcare, Inc., established in 2003, operates as a key provider of healthcare services throughout the United States. The company's core business involves the ownership and management of skilled nursing facilities alongside various assisted and senior living communities. Its operations are organized into three distinct divisions: Inpatient Services, Rehabilitation Therapy Services, and Other Services. Genesis Healthcare furnishes a wide array of rehabilitation therapies, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. Additionally, it extends its offerings to encompass specialized medical support, such as physician services, staffing solutions, and other health-related provisions. As of December 31, 2020, its inpatient care network comprised approximately 341 facilities situated across 24 states. Concurrently, its rehabilitation and respiratory therapy services were delivered to around 1,400 healthcare locations spanning 42 states, the District of Columbia, and China. The entity officially rebranded to Genesis HealthCare, Inc. in February 2015, having formerly been known as FC-GEN Operations Investment, LLC.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q3 2019 | Nov 8, 2019 | $0.40+433.33% vs estimate | $1.12B |
|---|
THE ANALYST VIEW
13 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
New You, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01-$0.00 (-24.81%)
Acorda Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.94% below the high.
$0.00$0.00 (0.0%)
Advanzeon Solutions, Inc.: Healthcare · Medical - Care Facilities.
$0.00$0.00 (0.0%)
MagForce AG: Healthcare · Medical - Devices.
$0.00$0.00 (0.0%)
Navidea Biopharmaceuticals, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.77% below the high.
$0.00$0.00 (0.0%)
Nanomix Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
NeonMind Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.67% below the high.
$0.00-$0.00 (0.0%)
MobileSmith, Inc.: Healthcare · Medical - Healthcare Information Services.